Patents Assigned to AGMEL S.A. DE C.V.
  • Publication number: 20190060341
    Abstract: A saponin and sapogenin extract recovered from plants of the Agavaceae family in the form of an extract or its purified form which has beneficial effects on the organism of mammals in relation to the prevention or treatment of metabolic disorders such as obesity, metabolic syndrome, diabetes and their related pathologies in mammals, including humans and further beneficial effects on lipid metabolism, glucose metabolism, energy expenditure, and gut microbiota health. Other aspects of the invention comprise a composition made of said saponin and sapogenin extract and methods for using said extract.
    Type: Application
    Filed: October 16, 2015
    Publication date: February 28, 2019
    Applicants: INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY, INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN, AGMEL S.A. DE C.V.
    Inventors: Ana María LEAL DÍAZ, Janet Alejandra GUTIÉRREZ URIBE, Nimbe TORRES Y TORRES, Armando Roberto TOVAR PALACIO, Lilia Guadalupe NORIEGA LÓPEZ
  • Patent number: 9585928
    Abstract: The present invention comprises an agave extract stored for at least eight weeks, having phytochemicals preferably selected from the group comprising flavonoids, polycosanols and sapogenins, that inhibit cancer cell growth over cells of breast and lymphoma and which provides the agave extract with antioxidant and chemopreventive properties.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: March 7, 2017
    Assignees: INSTITUTO TECHNOLOGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY, AGMEL S.A. DE C.V.
    Inventors: Janet Alejandra Gutierrez Uribe, Liliana Santos-Zea, Sergio Roman Othon Serna Saldivar
  • Publication number: 20130209588
    Abstract: The present invention comprises an agave extract stored for at least eight weeks, having phytochemicals preferably selected from the group comprising flavonoids, polycosanols and sapogenins, that inhibit cancer cell growth over cells of breast and lymphoma and which provides the agave extract with antioxidant and chemopreventive properties.
    Type: Application
    Filed: March 25, 2013
    Publication date: August 15, 2013
    Applicants: AGMEL S.A. DE C.V., Instituto Technologico Y De Estudios Superiores De Monterrey
    Inventors: Instituto Technologico Y De Estudios Superiores De Monterrey, AGMEL S.A. DE C.V.